SA
Go ProLog In
CMPX
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
15 analysts·Moderate coverage
75
Score
15 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
15100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$9.00
+391.8%
Consensus
$10.00
+446.4%
Bull
$15.00
+719.7%
12-Month Target Range15 analysts
$9.00$10.00$15.00
Current $1.83Consensus
Current Price
$1.83
Upside to Consensus
$8.17

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev—
EPS—
FY2028
Rev+377.05%
EPS—
FY2029
Rev+112.29%
EPS—

Earnings Surprises

Recent Analyst Actions

Mar 5, 2026Jefferies
Compass Therapeutics (CMPX) PT Raised to $9 at Jefferies
Target:$9.00
+62.7%from $5.53
Feb 13, 2026Craig-Hallum
Compass Therapeutics initiated with a Buy at Craig-Hallum
Target:$15.00
+130.1%from $6.52
Feb 4, 2026Canaccord Genuity
Compass Therapeutics price target raised to $13 from $10 at Canaccord
Target:$13.00
+102.5%from $6.42
Jan 6, 2026Raymond James
Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX)
Target:$9.00
+84.0%from $4.89
Dec 3, 2025JMP Securities
Compass Therapeutics initiated with an Outperform at Citizens JMP
Target:$10.00
+91.6%from $5.22
Oct 6, 2025Compass Point
Compass Therapeutics initiated with an Outperform at LifeSci Capital
Target:$10.00
+170.3%from $3.70
Apr 2, 2025Leerink Partners
Compass Therapeutics upgraded to Outperform from Market Perform at Leerink
Target:$6.00
+255.0%from $1.69
Sep 16, 2024Compass Point
Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) to Buy
Target:$5.00
+203.0%from $1.65

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance